Skip to Content

46 Results Found

  • Article
  • Open Access
1 Citations
1,220 Views
13 Pages

Outcome and Toxicity of Moderately Hypofractionated Post-Prostatectomy Radiotherapy: A Retrospective Study

  • Rocchina Vilella,
  • Fiorella D’Auria,
  • Luciana Valvano,
  • Barbara D’Andrea and ,
  • Antonietta Montagna,
  • Giovanni Castaldo,
  • Ilaria Benevento,
  • Angela Pia Solazzo,
  • Manuela Botte and
  • Luciana Rago
  • + 7 authors+ 2 authors

12 December 2025

Background: In this study, we retrospectively analyzed clinical and toxicity outcomes of 67 prostate cancer (PCa) patients undergoing moderately hypofractionated radiotherapy (RT) after prostatectomy, with adjuvant or salvage intent. Methods: Irradia...

(This article belongs to the Special Issue Feature Papers in Section “Cancer and Cancer-Related Research”)
  • Article
  • Open Access
140 Views
17 Pages

Efficiency Gain and Early Toxicity Profile of Ultra—Versus Moderate-Hypofractionation: A Matched Real-World Comparison of the Two Current Standard Schedules for Adjuvant Breast Radiotherapy

  • Angela Barillaro,
  • Mara Caroprese,
  • Christina A. Goodyear,
  • Emanuele Chioccola and ,
  • Gianluca Valerio,
  • Giuseppe Salzano,
  • Caterina Oliviero,
  • Stefania Clemente,
  • Mauro Buono and
  • Roberto Pacelli
  • + 7 authors+ 2 authors

2 November 2026

Background: Ultra-hypofractionation (UHF) and moderate-hypofractionation (MHF) represent standard adjuvant radiotherapy (RT) schedules in breast cancer (BC). This study evaluates the departmental workflow impact and early physician-assessed toxicity...

  • Review
  • Open Access
2,312 Views
24 Pages

Is Moderately Hypofractionated Radiotherapy a Safe and Effective Strategy for Cervical Cancer?—A Review of Current Evidence

  • Hui Xiao,
  • Fuxin Guo,
  • Zhenyu Wang,
  • Kangjia Pei and ,
  • Shuhua Wei,
  • Ang Qu,
  • Junjie Wang and
  • Ping Jiang
  • + 3 authors+ 0 author

Cervical cancer (CC) remains a leading cause of cancer-related mortality, particularly in low- and middle-income countries (LMICs), despite advancements in HPV vaccination and screening. Radiotherapy (RT) plays a critical role in managing CC, but con...

(This article belongs to the Section Gynecologic Oncology)
  • Article
  • Open Access
4 Citations
2,822 Views
13 Pages

Patient-Reported Quality of Life Outcomes after Moderately Hypofractionated and Normofractionated Proton Therapy for Localized Prostate Cancer

  • Koichiro Nakajima,
  • Hiromitsu Iwata,
  • Yukiko Hattori,
  • Kento Nomura and ,
  • Kensuke Hayashi,
  • Toshiyuki Toshito,
  • Yukihiro Umemoto,
  • Shingo Hashimoto,
  • Hiroyuki Ogino and
  • Yuta Shibamoto
  • + 5 authors+ 0 author

20 January 2022

We retrospectively evaluated the three-year patient-reported quality of life (QOL) after moderately hypofractionated proton therapy (MHPT) for localized prostate cancer in comparison with that after normofractionated PT (NFPT) using the Expanded Pros...

(This article belongs to the Special Issue Prostate Cancer Radiotherapy: Recent Advances and Challenges)
  • Article
  • Open Access
883 Views
22 Pages

Moderately Hypofractionated Online Adaptive Radiotherapy for Cervical Cancer: A Prospective Study of Feasibility, Acute Toxicity and Dosimetric Benefits

  • Zheng Zeng,
  • Yining Chen,
  • Xiangyin Meng,
  • Yuliang Sun and ,
  • Junfang Yan,
  • Ke Hu and
  • Fuquan Zhang
  • + 2 authors+ 0 author

4 August 2026

Background/Objectives: Moderately hypofractionated radiotherapy (MHRT) may shorten treatment duration for cervical cancer but raises concerns regarding toxicity due to substantial interfractional pelvic organ motion. This prospective study evaluated...

(This article belongs to the Special Issue Clinical Application of Proton Therapy and Advanced Radiotherapy in Gynecological Cancer)
  • Article
  • Open Access
15 Citations
5,820 Views
18 Pages

Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer

  • Nadia Gisella Di Muzio,
  • Chiara Lucrezia Deantoni,
  • Chiara Brombin,
  • Claudio Fiorino and ,
  • Cesare Cozzarini,
  • Flavia Zerbetto,
  • Paola Mangili,
  • Roberta Tummineri,
  • Italo Dell’Oca and
  • Andrei Fodor
  • + 11 authors+ 6 authors

3 October 2021

Aims: To report 10-year outcomes of WPRT and HD moderately hypofractionated SIB to the prostate in UIR, HR, and VHR PCa. Methods: From 11/2005 to 12/2015, 224 UIR, HR, and VHR PCa patients underwent WPRT at 51.8 Gy/28 fractions and SIB at 74.2 Gy (EQ...

(This article belongs to the Collection Prostate Cancer: Pathophysiology, Pathology and Therapy)
  • Study Protocol
  • Open Access
52 Citations
7,504 Views
18 Pages

PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial

  • Constantinos Zamboglou,
  • Simon K. B. Spohn,
  • Sonja Adebahr,
  • Maria Huber and ,
  • Simon Kirste,
  • Tanja Sprave,
  • Christian Gratzke,
  • Ronald C. Chen,
  • Ernst Günther Carl and
  • Anca L. Grosu
  • + 11 authors+ 6 authors

18 November 2021

Technical advances in radiotherapy (RT) treatment planning and delivery have substantially changed RT concepts for primary prostate cancer (PCa) by (i) enabling a reduction of treatment time, and by (ii) enabling safe delivery of high RT doses. Sever...

(This article belongs to the Special Issue Diagnostic and Treatment for Three Urological Cancers: Bladder Cancer, Kidney Cancer and Prostate Cancer)
  • Article
  • Open Access
1,451 Views
17 Pages

Ultra- and Moderately Hypofractionated Radiotherapy for Inoperable Cholangiocarcinoma: A Single-Institution Retrospective Analysis

  • Saheli Saha,
  • Cameron Lee,
  • Zhihui Amy Liu,
  • Michael Yan and ,
  • Laura Ann Dawson,
  • Ali Hosni Abdalaty,
  • Jelena Lukovic,
  • Rebecca Wong,
  • Aisling Barry and
  • Aruz Mesci
  • + 8 authors+ 3 authors

1 December 2025

Systemic therapy is the mainstay of treatment in inoperable cholangiocarcinoma (CCA). The aim of this study was to evaluate the overall survival (OS), progression-free survival (PFS), recurrence patterns, and the association between biliary complicat...

(This article belongs to the Section Gastrointestinal Oncology)
  • Article
  • Open Access
7 Citations
2,624 Views
15 Pages

Objective, Clinician- and Patient-Reported Evaluation of Late Toxicity Following Adjuvant Radiation for Early Breast Cancer: Long-Term Follow-Up Results of a Randomised Series

  • Cas Stefaan Dejonckheere,
  • Alina Abramian,
  • Kira Lindner,
  • Anne Bachmann and ,
  • Katharina Layer,
  • Teresa Anzböck,
  • Julian Philipp Layer,
  • Gustavo Renato Sarria,
  • Davide Scafa and
  • Leonard Christopher Schmeel
  • + 9 authors+ 4 authors

22 June 2023

Background and Purpose: This study aimed to differentially assess the frequency and severity of late radiation-induced toxicity following adjuvant whole-breast irradiation for early breast cancer with conventional fractionation (CF) and moderate hypo...

(This article belongs to the Special Issue Advances in Breast Cancer Radiotherapy: Implications for Current and Future Practice)
  • Article
  • Open Access
2 Citations
2,517 Views
20 Pages

Comprehensive 3DCRT Hypofractionated Radiotherapy Schedule for Localized Prostate Adenocarcinoma in the Era of IMRT: Dosimetric and Endoscopic Analysis

  • Andromachi Kougioumtzopoulou,
  • Nick Syrigos,
  • Anna Zygogianni,
  • Ioannis Georgakopoulos and ,
  • Kalliopi Platoni,
  • George Patatoukas,
  • Kimon Tzannis,
  • Aristotelis Bamias,
  • Nikolaos Kelekis and
  • Vasileios Kouloulias
  • + 5 authors+ 0 author

18 March 2024

Background: Moderate hypofractionated radiotherapy (MHRT) has emerged as the preferred treatment modality for localized prostate cancer based on randomized controlled studies regarding efficacy and toxicity using contemporary radiotherapy techniques....

(This article belongs to the Special Issue Cancer-Therapy-Related Adverse Events)
  • Article
  • Open Access
15 Citations
5,182 Views
11 Pages

Ultra-Hypofractionated vs. Moderate Fractionated Whole Breast Three Dimensional Conformal Radiotherapy during the COVID-19 Pandemic

  • Olivera Ivanov,
  • Aleksandra Milovančev,
  • Borislava Petrović,
  • Nataša Prvulović Bunović and ,
  • Jelena Ličina,
  • Marko Bojović,
  • Ivan Koprivica,
  • Milijana Rakin,
  • Milana Marjanović and
  • Nensi Lalić
  • + 6 authors+ 1 author

Background and Objectives: Reducing time of treatment during COVID-19 outbreaks has been recommended by the leading Radiation Oncology societies. Still minimizing radiation induced tissue toxicity is one of the most important issues in breast cancer...

(This article belongs to the Topic Cancer Biology and Radiation Therapy)
  • Article
  • Open Access
2 Citations
3,770 Views
13 Pages

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer

  • Hideya Yamazaki,
  • Gen Suzuki,
  • Norihiro Aibe,
  • Daisuke Shimizu and ,
  • Takuya Kimoto,
  • Koji Masui,
  • Ken Yoshida,
  • Satoaki Nakamura,
  • Yasutoshi Hashimoto and
  • Haruumi Okabe
  • + 5 authors+ 0 author

31 December 2021

The purpose of this study was to compare the toxicity (first endpoint) and efficacy (second endpoint) of ultrahypofractionated radiotherapy (UHF) and dose-escalated conventional to moderate hypofractionated radiotherapy (DeRT) for clinically localize...

(This article belongs to the Special Issue Stereotactic Body Radiotherapy for Various Cancers: Recent Advances and Future)
  • Article
  • Open Access
124 Views
21 Pages

Impact of a Reminder App on Bladder Filling During Moderately Hypo-Fractionated Radiotherapy for Prostate Cancer: Results of the REFILL-PAC-HYPO Trial

  • Dirk Rades,
  • Stefan Janssen,
  • Laura Doehring,
  • Jan-Dirk Küter and ,
  • Michael von Staden,
  • Ahmed Al-Salool,
  • Julia Koeck,
  • Justus Domschikowski,
  • Christian Felix Schulz and
  • Charlotte Kristiansen
  • + 7 authors+ 2 authors

3 November 2026

Background/Objectives: Moderate hypo-fractionation is frequently used for irradiation of prostate cancer. Irrespective of dose fractionation, radiotherapy can lead to radiation cystitis. To reduce urinary toxicity, it is important to avoid bladder vo...

(This article belongs to the Special Issue Genitourinary Tumors and Radiation Therapy: Current Advances and Future Directions)
  • Feature Paper
  • Article
  • Open Access
6 Citations
2,741 Views
15 Pages

Multi-Institutional Comparison of Ablative 5-Fraction Magnetic Resonance-Guided Online Adaptive Versus 15/25-Fraction Computed Tomography-Guided Moderately Hypofractionated Offline Adapted Radiation Therapy for Locally Advanced Pancreatic Cancer

  • Michael D. Chuong,
  • Eileen M. O’Reilly,
  • Robert A. Herrera,
  • Melissa Zinovoy and ,
  • Kathryn E. Mittauer,
  • Muni Rubens,
  • Adeel Kaiser,
  • Paul B. Romesser,
  • Nema Bassiri-Gharb and
  • Marsha Reyngold
  • + 13 authors+ 8 authors

7 August 2025

Background: Radiation dose escalation for locally advanced pancreatic cancer (LAPC) using stereotactic magnetic resonance (MR)-guided online adaptive radiation therapy (SMART) or computed tomography (CT)-guided moderately hypofractionated ablative ra...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
13 Citations
7,146 Views
16 Pages

Hypofractionated Radiotherapy in Gynecologic Malignancies—A Peek into the Upcoming Evidence

  • Razan Amjad,
  • Nataliya Moldovan,
  • Hamid Raziee,
  • Eric Leung and ,
  • David D’Souza and
  • Lucas C. Mendez
  • + 1 author+ 0 author

15 January 2024

Radiotherapy (RT) has a fundamental role in the treatment of gynecologic malignancies, including cervical and uterine cancers. Hypofractionated RT has gained popularity in many cancer sites, boosted by technological advances in treatment delivery and...

(This article belongs to the Special Issue Hypofractionated Radiotherapy in Cancer Treatments)
  • Article
  • Open Access
1,466 Views
10 Pages

6 November 2025

Purpose/Objective(s): Adjuvant radiation therapy (RT) is an effective treatment in the management of patients with breast cancer. Evidence supports both standard fractionation and, more recently, moderate hypofractionation and ultra hypofractionation...

(This article belongs to the Section Breast Cancer)
  • Systematic Review
  • Open Access
5 Citations
6,116 Views
15 Pages

Evidences on the Use of Hypofractionation in Postoperative/Salvage Radiotherapy for Prostate Cancer: Systematic Review of the Literature and Recent Developments

  • Camille Roukoz,
  • Amina Lazrek,
  • Lilia Bardoscia,
  • Giuseppe Rubini and ,
  • Chieh-Min Liu,
  • Anne-Agathe Serre,
  • Angela Sardaro,
  • Dino Rubini,
  • Sarah Houabes and
  • Salvatore Cozzi
  • + 6 authors+ 1 author

18 December 2024

Background: Radical prostatectomy (RP) is one possible curative treatment for localized prostate cancer. Despite that, up to 40% of patients will later relapse. Currently, post-operative radiotherapy (PORT) courses deliver 1.8–2 Gy daily to rea...

(This article belongs to the Section Cancer Therapy)
  • Systematic Review
  • Open Access
1 Citations
1,136 Views
15 Pages

Radiotherapy De-Escalation in Younger Patients with Breast Cancer: Are We There Yet?

  • Ioannis Georgakopoulos,
  • Georgios Nikiforos Ntoumas,
  • Pantelis Skarlos,
  • Alexia Sidiropoulou and ,
  • Georgia Lymperopoulou,
  • Ioanna Kollarou,
  • Konstantina Perdikari,
  • Flora Zagouri and
  • Maria Tolia
  • + 4 authors+ 0 author

16 February 2026

Background/Objectives: Radiotherapy de-escalation is an established strategy in the management of early breast cancer, supported by randomized evidence predominantly derived from older patient populations. Younger women remain underrepresented in de-...

(This article belongs to the Special Issue Feature Review for Cancer Therapy: 2nd Edition)
  • Review
  • Open Access
10 Citations
4,429 Views
35 Pages

Predictive Factors for Gastrointestinal and Genitourinary Toxicities in Prostate Cancer External Beam Radiotherapy: A Scoping Review

  • Jerry C. F. Ching,
  • Kelvin C. K. Liu,
  • Isaac K. H. Pang,
  • Alexander J. Nicol and ,
  • Vincent W. S. Leung,
  • Jing Cai and
  • Shara W. Y. Lee
  • + 2 authors+ 0 author

Advancements in radiotherapy (RT) techniques such as intensity modulation, image guidance, and hypofractionation have facilitated a satisfactory survival outcome in prostate cancer (PCa) patients. However, virtually all PCa patients suffer from vario...

(This article belongs to the Special Issue Clinical Diagnosis and Management in Urology)
  • Article
  • Open Access
1 Citations
1,839 Views
10 Pages

Clinical Value of Bone Radiotherapy in a Prospective Cohort of Metastatic Breast Cancer Treated with Anti-CDK4/6

  • Edy Ippolito,
  • Lucrezia Toppi,
  • Sofia Carrafiello,
  • Carlo Greco and ,
  • Michele Fiore,
  • Rita Alaimo,
  • Salvatore Minuti,
  • Francesco Pantano,
  • Giuseppe Casale and
  • Sara Ramella
  • + 8 authors+ 3 authors

1 July 2025

Background: CDK4/6 inhibitor plus ET is a standard treatment for advanced HR+ BC. This study evaluates the efficacy and safety of CDK4/6 inhibitors with concurrent RT (SBRT and non-SBRT) in terms of pain, analgesic therapy changes, toxicities, and ne...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
4 Citations
2,830 Views
12 Pages

Hypofractionated Post-Prostatectomy Radiotherapy in 16 Fractions: A Single-Institution Outcome

  • Pavol Dubinsky,
  • Vladimir Vojtek,
  • Katarina Belanova,
  • Natalia Janickova and ,
  • Noemi Balazova and
  • Zuzana Tomkova
  • + 1 author+ 0 author

23 July 2023

Background: The optimal hypofractionated schedule of post-prostatectomy radiotherapy remains to be established. We evaluated treatment outcomes and toxicity of moderately hypofractionated post-prostatectomy radiotherapy in 16 daily fractions delivere...

(This article belongs to the Special Issue Prostate Cancer: 2nd Edition)
  • Perspective
  • Open Access
5 Citations
3,119 Views
12 Pages

8 May 2023

Altered fractionation concepts and especially moderate hypo-fractionation are evaluated as alternatives to standard treatment for head and neck squamous cell carcinoma (HNSCC), associated with or not concurrent with or sequential to chemotherapy. The...

(This article belongs to the Section Head and Neck Oncology)
  • Systematic Review
  • Open Access
10 Citations
4,555 Views
21 Pages

Economic Evaluations of Magnetic Resonance Image-Guided Radiotherapy (MRIgRT): A Systematic Review

  • Alessandra Castelluccia,
  • Pierpaolo Mincarone,
  • Maria Rosaria Tumolo,
  • Saverio Sabina and ,
  • Riccardo Colella,
  • Antonella Bodini,
  • Francesco Tramacere,
  • Maurizio Portaluri and
  • Carlo Giacomo Leo
  • + 4 authors+ 0 author

Objectives: This review systematically summarizes the evidence on the economic impact of magnetic resonance image-guided RT (MRIgRT). Methods: We systematically searched INAHTA, MEDLINE, and Scopus up to March 2022 to retrieve health economic studies...

(This article belongs to the Special Issue Promoting Innovation in Health Systems)
  • Review
  • Open Access
2 Citations
4,325 Views
11 Pages

New Challenges of Treatment for Locally Advanced Head and Neck Cancers in the Covid-19 Pandemic Era

  • Camil Ciprian Mireștean,
  • Anda Crișan,
  • Adina Mitrea,
  • Călin Buzea and ,
  • Roxana Irina Iancu and
  • Dragoș Petru Teodor Iancu
  • + 1 author+ 0 author

4 February 2021

Locally advanced head and neck cancer is a unique challenge for cancer management in the Covid-19 situation. The negative consequences of delaying radio-chemotherapy treatment make it necessary to prioritize these patients, the continuation of radiot...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
7 Citations
3,786 Views
12 Pages

Treatment Outcomes after Dose-Escalated Moderately Hypofractionated Radiotherapy for Frail Patients with High-Grade Glioma

  • Nalee Kim,
  • Hyunju Shin,
  • Do Hoon Lim,
  • Do-Hyun Nam and ,
  • Jung-Il Lee,
  • Ho Jun Seol,
  • Doo-Sik Kong,
  • Jung Won Choi,
  • Kyuha Chong and
  • Won Jae Lee
  • + 5 authors+ 0 author

21 December 2023

For high-grade glioma (HGG) patients with old age or poor performance status, hypofractionated radiotherapy (hypoRT) in 10–15 fractions is recommended. Also, limited data exist on the impact of salvage treatment after progression in frail patie...

(This article belongs to the Collection Advances in Geriatric Oncology: Exploring Practical Ways to Optimize Treatment in Older Patients with Cancer)
  • Article
  • Open Access
24 Citations
4,373 Views
10 Pages

Cost Minimization Analysis of Hypofractionated Radiotherapy

  • Hannah L. Yaremko,
  • Gordon E. Locke,
  • Ronald Chow,
  • Michael Lock and ,
  • Robert Dinniwell and
  • Brian P. Yaremko
  • + 1 author+ 0 author

30 January 2021

Early-stage breast cancer patients comprise a large proportion of patients treated with radiotherapy in Canada. Proponents have suggested that five-fraction hypofractionated radiotherapy for these patients would result in significant cost savings. An...

  • Review
  • Open Access
12 Citations
5,217 Views
15 Pages

Hypofractionated Radiotherapy in Localized, Low–Intermediate-Risk Prostate Cancer: Current and Future Prospectives

  • Maria Chiara Lo Greco,
  • Giulia Marletta,
  • Giorgia Marano,
  • Alessandro Fazio and ,
  • Emanuele Buffettino,
  • Arianna Iudica,
  • Rocco Luca Emanuele Liardo,
  • Roberto Milazzotto,
  • Pietro Valerio Foti and
  • Corrado Spatola
  • + 13 authors+ 8 authors

14 June 2023

At the time of diagnosis, the vast majority of prostate carcinoma patients have a clinically localized form of the disease, with most of them presenting with low- or intermediate-risk prostate cancer. In this setting, various curative-intent alternat...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
88 Views
28 Pages

12 November 2026

Purpose: To evaluate inter-modality agreement and differences in detection rates between 68Ga-PSMA PET/CT and mpMRI for primary staging in prostate cancer, and to assess their impact on radiotherapy (RT) target-volume personalization, organ-at-risk (...

(This article belongs to the Special Issue Prostate Cancer: 4th Edition)
  • Article
  • Open Access
6 Citations
4,454 Views
11 Pages

Prostate Cancer Treatment-Related Toxicity: Comparison between 3D-Conformal Radiation Therapy (3D-CRT) and Volumetric Modulated Arc Therapy (VMAT) Techniques

  • Fabrizio Tonetto,
  • Alessandro Magli,
  • Eugenia Moretti,
  • Andrea Emanuele Guerini and ,
  • Annarita Tullio,
  • Chiara Reverberi,
  • Tino Ceschia,
  • Luigi Spiazzi,
  • Francesca Titone and
  • Luca Triggiani
  • + 10 authors+ 5 authors

23 November 2022

Objective: This paper illustrates the results of a mono-institutional registry trial, aimed to test whether gastrointestinal (GI) and genitourinary (GU) toxicity rates were lower in localized prostate cancer patients treated with image-guided volumet...

(This article belongs to the Section Nephrology & Urology)
  • Article
  • Open Access
1 Citations
3,084 Views
15 Pages

16 April 2025

Background/Objectives: Clinical studies have shown a marked reduction in tumor control in prostate cancer treated with radically hypofractionated high-dose-rate brachytherapy (HDR-BT). The purpose of this study was to analyze the dose–response...

(This article belongs to the Section Cancer Therapy)
  • Systematic Review
  • Open Access
735 Views
15 Pages

Hypofractionated Versus Conventional Postmastectomy Radiotherapy in Implant-Based Breast Reconstruction: A Systematic Review and Meta-Analysis

  • Ji Hyeon Joo,
  • Yongkan Ki,
  • Youn-Joo Jung,
  • Hyun Yul Kim and ,
  • Ki Seok Choo,
  • Kyung Jin Nam and
  • Su Bong Nam
  • + 2 authors+ 0 author

22 July 2026

Background/Objectives: The safety of hypofractionated postmastectomy radiotherapy (HF-PMRT) in patients undergoing implant-based breast reconstruction remains uncertain because of concerns regarding radiation-related reconstructive complications. We...

(This article belongs to the Special Issue Radiation Therapy: Recent Trends and Future Perspectives)
  • Article
  • Open Access
1 Citations
1,911 Views
18 Pages

Temporal Validation of an FDG-PET-Radiomic Model for Distant-Relapse-Free-Survival After Radio-Chemotherapy for Pancreatic Adenocarcinoma

  • Monica Maria Vincenzi,
  • Martina Mori,
  • Paolo Passoni,
  • Roberta Tummineri and ,
  • Najla Slim,
  • Martina Midulla,
  • Gabriele Palazzo,
  • Alfonso Belardo,
  • Emiliano Spezi and
  • Nadia Gisella Di Muzio
  • + 10 authors+ 5 authors

20 March 2025

Background/Objectives: Pancreatic cancer is a very aggressive disease with a poor prognosis, even when diagnosed at an early stage. This study aimed to validate and refine a radiomic-based [18F]FDG-PET model to predict distant relapse-free survival (...

(This article belongs to the Special Issue Insights from the Editorial Board Member)
  • Article
  • Open Access
13 Citations
3,030 Views
13 Pages

Prediction of Radiotherapy Compliance in Elderly Cancer Patients Using an Internally Validated Decision Tree

  • Biche Osong,
  • Inigo Bermejo,
  • Kyu Chan Lee,
  • Seok Ho Lee and ,
  • Andre Dekker and
  • Johan van Soest
  • + 1 author+ 0 author

12 December 2022

This study aims to analyze the relationship between the available variables and treatment compliance in elderly cancer patients treated with radiotherapy and to establish a decision tree model to guide caregivers in their decision-making process. For...

(This article belongs to the Special Issue Personalized Radiation Therapy for Oncology)
  • Article
  • Open Access
658 Views
15 Pages

Association of Cardiac and Pulmonary CT Imaging Features with Respiratory Side Effects After Whole-Breast Radiotherapy

  • Marco Fois,
  • Alfonso Belardo,
  • Andrei Fodor,
  • Lucia Perna and ,
  • Laura Giannini,
  • Paola Mangili,
  • Gabriele Palazzo,
  • Marcella Pasetti,
  • Miriam Torrisi and
  • Claudio Fiorino
  • + 10 authors+ 5 authors

25 May 2026

Purpose: This paper aimed to identify dosimetric, clinical, and CT-based densitometric predictors of radiation-induced pulmonary events in breast cancer patients treated with moderately hypofractionated radiotherapy. Materials and Methods: A single-i...

(This article belongs to the Special Issue Personalized Radiotherapy in Cancer Care (2nd Edition))
  • Article
  • Open Access
14 Citations
4,426 Views
10 Pages

Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study

  • Alessandro Passardi,
  • Emanuela Scarpi,
  • Elisa Neri,
  • Elisabetta Parisi and ,
  • Giulia Ghigi,
  • Giorgio Ercolani,
  • Andrea Gardini,
  • Giuliano La Barba,
  • Flavia Pagan and
  • Antonino Romeo
  • + 9 authors+ 4 authors

13 May 2019

The aim of the study was to evaluate the safety and efficacy of a new chemo-radiotherapy regimen for patients with locally advanced pancreatic cancer (LAPC). Patients were treated as follows: gemcitabine 1000 mg/m2 on day 1, and oxaliplatin 100 mg/m2...

  • Article
  • Open Access
4 Citations
8,723 Views
14 Pages

Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer

  • Antonio Lazo,
  • Alejandro de la Torre-Luque,
  • Gregorio Arregui,
  • Daniel Rivas and ,
  • Ana Serradilla,
  • Joaquin Gómez,
  • Francisca Jurado,
  • María Isabel Núñez and
  • Escarlata López
  • + 4 authors+ 0 author

11 March 2022

This retrospective study aimed to provide some clinical outcomes regarding effectiveness, toxicity, and quality of life in PCa patients treated with dose-escalated moderately hypofractionated radiation therapy (HFRT). Patients received HFRT to a tota...

(This article belongs to the Section Cancer Biology)
  • Article
  • Open Access
9 Citations
2,870 Views
13 Pages

18 July 2023

The purpose of this work was to investigate the response of prostate cancer to different radiotherapy schedules, including hypofractionation, to evaluate potential departures from the linear–quadratic (LQ) response, to obtain the best-fitting p...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
2,044 Views
11 Pages

Plan Quality Comparison at Five Years in Two Cohorts of Breast Cancer Patients Treated with Helical Tomotherapy

  • Samantha Dicuonzo,
  • Maria Alessia Zerella,
  • Mattia Zaffaroni,
  • Maria Giulia Vincini and ,
  • Karl Amin,
  • Giuseppe Ronci,
  • Micol D’arcangelo,
  • Damaris Patricia Rojas,
  • Anna Morra and
  • Barbara Alicja Jereczek-Fossa
  • + 15 authors+ 10 authors

27 February 2025

Objectives: this study aimed to evaluate the evolution of planned dose distribution quality in two groups of breast cancer patients treated with hypofractionated intensity-modulated radiotherapy (IMRT) using Helical TomoTherapy® at our institute...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
33 Citations
5,326 Views
18 Pages

Pre-Operative Versus Post-Operative Radiosurgery of Brain Metastases—Volumetric and Dosimetric Impact of Treatment Sequence and Margin Concept

  • Rami A. El Shafie,
  • Eric Tonndorf-Martini,
  • Daniela Schmitt,
  • Dorothea Weber and ,
  • Aylin Celik,
  • Thorsten Dresel,
  • Denise Bernhardt,
  • Kristin Lang,
  • Philipp Hoegen and
  • Stefan Rieken
  • + 8 authors+ 3 authors

1 March 2019

Background: Pre-operative radiosurgery (SRS) preceding the resection of brain metastases promises to circumvent limitations of post-operative cavity SRS. It minimizes uncertainties regarding delineation and safety margins and could reduce dose exposu...

  • Feature Paper
  • Article
  • Open Access
11 Citations
4,378 Views
12 Pages

Accelerated Hypofractionated Active Raster-Scanned Carbon Ion Radiotherapy (CIRT) for Laryngeal Malignancies: Feasibility and Safety

  • Sati Akbaba,
  • Kristin Lang,
  • Thomas Held,
  • Olcay Cem Bulut and ,
  • Matthias Mattke,
  • Matthias Uhl,
  • Alexandra Jensen,
  • Peter Plinkert,
  • Stefan Rieken and
  • Sebastian Adeberg
  • + 7 authors+ 2 authors

18 October 2018

(1) Background: The authors present the first results of active raster-scanned carbon ion radiotherapy (CIRT) for radioresistant laryngeal malignancies regarding efficacy and toxicity. (2) Methods: 15 patients with laryngeal adenoid cystic carcinoma...

(This article belongs to the Special Issue New Developments in Radiotherapy)
  • Systematic Review
  • Open Access
5 Citations
4,369 Views
16 Pages

31 December 2022

The optimal thoracic radiotherapy (TRT) dose and fractionation for limited-stage small cell lung cancer (LS-SCLC) using modern techniques remain unclear. We conducted systematic review and meta-analyses of the efficacy and safety differences between...

(This article belongs to the Topic Advances in Radiotherapy and Prognosis)
  • Systematic Review
  • Open Access
3,538 Views
27 Pages

Stereotactic Body Radiation Therapy for High-Risk Prostate Cancer: A Systematic Review of the Literature

  • Raffaella Lucchini,
  • Rodrigo Cartes,
  • Ciro Franzese,
  • Lorenzo Lo Faro and ,
  • Luciana Di Cristina,
  • Giuseppe Roberto D’Agostino,
  • Marco Badalamenti,
  • Andrea Girlando,
  • Rosario Mazzola and
  • Marta Scorsetti
  • + 6 authors+ 1 author

4 February 2026

Background/Objectives: Stereotactic Body Radiation Therapy (SBRT) is increasingly used for localized prostate cancer (PCa), but evidence supporting its use in high-risk PCa (HRPC) remains limited. Standard management continues to favor conventional o...

  • Article
  • Open Access
2 Citations
4,118 Views
10 Pages

Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRT

  • Angelo Maggio,
  • Tiziana Rancati,
  • Marco Gatti,
  • Domenico Cante and ,
  • Barbara Avuzzi,
  • Cinzia Bianconi,
  • Fabio Badenchini,
  • Bruno Farina,
  • Paolo Ferrari and
  • Cesare Cozzarini
  • + 18 authors+ 13 authors

1 February 2024

Purpose: The purpose of this study is to study the evolution of quality of life (QoL) in the first 5 years following Intensity-modulated radiation therapy (IMRT) for prostate cancer (PCa) and to determine possible associations with clinical/treatment...

(This article belongs to the Special Issue Evolution of Treatments of Prostate Cancer: From Biology to Current Advanced Technologies)
  • Article
  • Open Access
2 Citations
2,082 Views
19 Pages

From Intensification to Optimization: Balancing Efficacy, Safety, and Costs in High-Risk Localized Soft Tissue Sarcomas

  • Bruno Fuchs,
  • Georg Schelling,
  • Christoph Glanzmann,
  • Gabriela Studer and
  • on behalf of the Swiss Sarcoma Network

21 May 2025

Background/Objectives: The SU2C-SARC032 randomized controlled trial (RCT) tested pembrolizumab combined with preoperative normofractionated radiotherapy as an intensified treatment for high-risk stage III resectable soft tissue sarcoma (STS), demonst...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
1,526 Views
15 Pages

Omitting Elective Pelvic Nodes Irradiation in High Risk Prostate Cancer: Report on 43 Consecutive Elderly Patients

  • Emanuele Chioccola,
  • Mara Caroprese,
  • Christina Amanda Goodyear,
  • Angela Barillaro and ,
  • Gianluca Valerio,
  • Caterina Oliviero,
  • Mauro Buono,
  • Stefania Clemente,
  • Antonio Farella and
  • Roberto Pacelli
  • + 6 authors+ 1 author

24 March 2026

Background: Radiotherapy (RT) combined with androgen deprivation therapy (ADT) is a standard treatment for non-metastatic high-risk (HR) prostate cancer (PC). However, the benefit of elective nodal irradiation (ENI) in clinically node-negative (cN0)...

(This article belongs to the Special Issue Personalized Radiation Therapy for Cancers: Current Status and Future Perspectives)